Connect your AI

BioLife Solutions BLFS Accrued Compensation

Accrued Compensation at other companies

STERISSTE

——

Other financials

Income statement

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Profitability

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityCurrent.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's accrued compensation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BioLife Solutions's accrued compensation?: BioLife Solutions (BLFS) reported accrued compensation of $4.03M in Q1 2026.
How has BioLife Solutions's accrued compensation changed year-over-year?: BioLife Solutions's accrued compensation increased by 7.2% year-over-year, from $3.76M to $4.03M.
What is the long-term trend for BioLife Solutions's accrued compensation?: Over 3 years (2022 to 2025), BioLife Solutions's accrued compensation has grown at a 5.3% compound annual growth rate (CAGR), from $5.08M to $5.93M.
What does accrued compensation mean?: Employee wages, salaries, bonuses, commissions, and benefits earned but not yet paid as of the reporting date.